Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, manganese(3+) salt (1:1)

1,2,3-Propanetricarboxylic acid, 2-hydroxy-, manganese(3+) salt (1:1)

1,2,3-Propanetricarboxylic acid, 2-hydroxy-, manganese(3+) salt (1:1) structure

1,2,3-Propanetricarboxylic acid, 2-hydroxy-, manganese(3+) salt (1:1) 

structure
  • CAS No:

    5968-88-7

  • Formula:

    C6H8O7.Mn

  • Chemical Name:

    1,2,3-Propanetricarboxylic acid, 2-hydroxy-, manganese(3+) salt (1:1)

  • Synonyms:

    1,2,3-Propanetricarboxylic acid,2-hydroxy-,manganese(3+) salt (1:1);Citric acid,manganese(3+) salt (1:1);Manganese citrate (Mn(O7C6H5));Manganese citrate;13001-53-1

  • Categories:

    Organic Chemistry  >  Organometalate

1,2,3-Propanetricarboxylic acid, 2-hydroxy-, manganese(3+) salt (1:1) Basic Attributes

244.04

243.94200

TC17243R3G

White powder

Characteristics

140.62000

155.2ºC

Soluble in water in presence of sodium citrate

Safety Information

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

Substance added directly to human food affirmed as generally recognized as safe (GRAS).|Trace minerals added to animal feeds. These substances added to animal feeds as nutritional dietary supplements are generally recognized as safe when added at levels consistent with good feeding practice. Element: Manganese; Source compound: manganese citrate (soluble). (All substances listed may be in anhydrous or hydrated form.) /Manganese citrate (soluble)/

USEPA; Locating and Estimating Air Emissions from Sources of Manganese (1985) EPA-450/4-84-007h|USEPA; Health Assessment Document: Manganese (1984) EPA-600/8-83-013F|WHO; Environ Health Criteria: Manganese (1981)|WHO; Environ Health Criteria: Manganese-Executive Summary (1981)

SRP: Local exhaust ventilation should be applied wherever there is an incidence of point source emissions or dispersion of regulated contaminants in the work area. Ventilation control of the contaminant as close to its point of generation is both the most economical and safest method to minimize personnel exposure to airborne contaminants.

Permissible Exposure Limit: Table Z-1 Ceiling value: 5 mg/cu m. /Manganese cmpd (as Mn)/

Recommended Exposure Limit: 10 Hr Time-Weighted Avg: 1 mg/cu m. /Manganese compounds and fume (as Mn)/|Recommended Exposure Limit: 15 Min Short-Term Exposure Limit: 3 mg/cu m. /Manganese compounds and fume (as Mn)/

Listed as a hazardous air pollutant (HAP) generally known or suspected to cause serious health problems. The Clean Air Act, as amended in 1990, directs EPA to set standards requiring major sources to sharply reduce routine emissions of toxic pollutants. EPA is required to establish and phase in specific performance based standards for all air emission sources that emit one or more of the listed pollutants. Manganese citrate is included on this list.|... Substances for which a Federal Register notice has been published that included consideration of the serious health effects, including cancer, form ambient air exposure to the substance. Manganese (50 FR 32627; Aug. 13, 1985) is included on this list. /Manganese/

Drug Information

Basic treatment: Establish a patent airway. Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if necessary. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for pulmonary edema and treat if necessary ... . Monitor for shock and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with normal saline during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 ml/kg up to 200 ml of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool ... . /Manganese and related compounds/|Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the patient who is unconscious or in severe respiratory distress. Monitor cardiac rhythm and treat arrhythmias if necessary ... . Start an IV with D5W /SRP: "To keep open", minimal flow rate/. Use lactated Ringer's if signs of hypovolemia are present. Consider drug therapy for pulmonary edema ... . For hypotension with signs of hypovolemia, administer fluid cautiously. Consider vasopressors for hypotension with a normal fluid volume. Watch for signs of fluid overload ... . Use proparacaine hydrochloride to assist eye irrigation ... . /Manganese and related compounds/

1,2,3-Propanetricarboxylic acid, 2-hydroxy-, manganese(3+) salt (1:1) Use and Manufacturing

Methods of Manufacturing

Action of citric acid on manganese hydroxide

Uses

Feed additive, food additive, and dietary supplement

1,2,3-Propanetricarboxylic acid, 2-hydroxy-, manganese(3+) salt (1:1): INACTIVE

Computed Properties

Molecular Weight:244.04
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:7
Rotatable Bond Count:2
Exact Mass:243.941571
Monoisotopic Mass:243.941571
Topological Polar Surface Area:141
Heavy Atom Count:14
Complexity:211
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.